Quick Answer
Tempest Therapeutics, Inc. reported Shares Outstanding of 4.93 million shares for fiscal year 2025.
Tempest Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 4.93M | +45.7% |
| 2024 | 3.38M | -84.7% |
| 2023 | 22.05M | +109.6% |
| 2022 | 10.52M | +52.2% |
| 2021 | 6.91M | -63.6% |
| 2020 | 19.00M | +4.0% |
| 2019 | 18.27M | +36.7% |
| 2018 | 13.36M | +5322.4% |
| 2017 | 246,347 | -99.3% |
| 2016 | 35.64M | +30.6% |
| 2015 | 27.30M | +13.3% |
| 2014 | 24.08M | +37.3% |
| 2013 | 17.54M | +39.0% |
| 2012 | 12.62M | +943.4% |
| 2011 | 1.21M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 4.44M | -83.3% | +0.1% |
| June 30, 2025 | 4.44M | -81.9% | +26.1% |
| March 31, 2025 | 3.52M | -84.2% | +4.1% |
| December 31, 2024 | 3.38M | -84.7% | -87.3% |
| September 30, 2024 | 26.57M | +85.5% | +8.5% |
| June 30, 2024 | 24.48M | +94.5% | +10.2% |
| March 31, 2024 | 22.22M | +110.4% | +0.8% |
| December 31, 2023 | 22.05M | +109.6% | +53.9% |
- Tempest Therapeutics, Inc. showed an increase of +45.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2011–2025 period, Tempest Therapeutics, Inc.’s shares outstanding has grown by 307.3% (from 1.21 million shares to 4.93 million shares).
- The most recent figure is from Tempest Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: